Review of Studies Comparing Panretinal Photocoagulation and Anti-Vascular Endothelial Growth Factor Therapy in the Treatment of Proliferative Diabetic Retinopathy-Reference-Cited by-同舟云学术

Review of Studies Comparing Panretinal Photocoagulation and Anti-Vascular Endothelial Growth Factor Therapy in the Treatment of Proliferative Diabetic Retinopathy

Published:2022-02-21 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Gunasekaran Thiruvarasu,Gunasekaran Yuarrani,Tze Hui Pua

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference57 articles.

1. Diagnosis and classification of diabetes mellitus;Diabetes Care,2009

2. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review;Ting DS;Clin Exp Ophthalmol,2016

3. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030;Wild S;Diabetes Care,2004

4. Global Report on Diabetes;World Health Organization,2016

5. World Health Organization. Prevention of blindness from diabetes mellitus. report of a WHO consultation in Geneva, Switzerland, 9-11 November 2005. (2006). https://apps.who.int/iris/handle/10665/43576.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights Into Visual Rehabilitation: Pan-Retinal Photocoagulation for Proliferative Diabetic Retinopathy;Cureus;2024-02-15

2. Beneficial Effect of Sirolimus-Pretreated Mesenchymal Stem Cell Implantation on Diabetic Retinopathy in Rats;Biomedicines;2024-02-07

3. Cost-effectiveness of the anti-vascular endothelial growth factor intravitreal injection and panretinal photocoagulation for patients with proliferative diabetic retinopathy in South Korea;BMC Health Services Research;2023-12-11